Clinical Trials Browser

Phase EARLY_PHASE1 × Endometrial Neoplasms × Dasatinib × Clear all

NCT01482728 2016-05-13

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

Phase EARLY_PHASE1 Completed

Endometrial Neoplasms